Hugh Pross
Affiliations: | Queen's University, Canada, Kingston, Ontario, Canada |
Area:
Cell Biology, Pharmacology, OncologyGoogle:
"Hugh Pross"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Siemens DR, Hu N, Sheikhi AK, et al. (2008) Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: role of nitric oxide. Cancer Research. 68: 4746-53 |
| Savas B, Kerr PE, Pross HF. (2006) Lymphokine-activated killer cell susceptibility and adhesion molecule expression of multidrug resistant breast carcinoma. Cancer Cell International. 6: 24 |
| Savas B, Kerr PE, Ustun H, et al. (1998) Lymphokine-activated killer cell susceptibility and multidrug resistance in small cell lung carcinoma. Anticancer Research. 18: 4355-61 |
| Savas B, Cole SP, Tsuruo T, et al. (1996) P-glycoprotein-mediated multidrug resistance and lymphokine-activated killer cell susceptibility in ovarian carcinoma. Journal of Clinical Immunology. 16: 348-57 |
| McPherson R, Tsoukas C, Baines MG, et al. (1994) Effects of lovastatin on natural killer cell function and other immunological parameters in man. Journal of Clinical Immunology. 13: 439-44 |
| Elliott BE, Ekblom P, Pross H, et al. (1994) Anti-beta 1 integrin IgG inhibits pulmonary macrometastasis and the size of micrometastases from a murine mammary carcinoma. Cell Adhesion and Communication. 1: 319-32 |
| Lu Y, Raptis L, Anderson S, et al. (1993) Ras modulates commitment and maturation of 10T1/2 fibroblasts to adipocytes. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 70: 1249-57 |
| Savas B, Cole SP, Akoglu TF, et al. (1992) P-glycoprotein-mediated multidrug resistance and cytotoxic effector cells. Natural Immunity. 11: 177-92 |
| Elliott BE, Barron A, Maxwell L, et al. (1991) Capacity of CD8+ T cells to reject immunogenic variants of a spontaneous murine carcinoma: lack of non-specific (NK1.1+) effector mechanisms. Scandinavian Journal of Immunology. 33: 683-90 |
| Morris DG, Pross HF. (1989) Studies of lymphokine-activated killer (LAK) cells. I. Evidence using novel monoclonal antibodies that most human LAK precursor cells share a common surface marker. The Journal of Experimental Medicine. 169: 717-36 |